Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF CASH FLOWS

v3.23.3
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Operating activities:    
Consolidated net income $ 417.2 $ 591.1
Adjustments to reconcile consolidated net income to net cash provided by operating activities:    
Depreciation and amortization 461.0 424.1
Stock-based compensation expense 61.3 50.4
Deferred income taxes (67.9) 47.9
Gain on fair market value adjustment and gain on sale of equity investments (13.8) (20.2)
Changes in assets and liabilities, excluding effects of acquisitions:    
Accounts receivable, net (86.4) (133.6)
Other assets, current and long-term (16.0) (32.0)
Current and long term liabilities, excluding debt 39.3 (496.0)
Cash provided by operating activities 794.7 431.7
Investing activities:    
Capital expenditures (455.6) (468.4)
Acquisitions, net of cash acquired (276.0) (437.5)
Cash received from divestitures 6.9 98.8
Cash used in investing activities (724.7) (807.1)
Financing activities:    
Net short-term borrowings (83.6) (162.1)
Payments on long-term debt (575.0) 0.0
Borrowings on long-term debt 872.9 749.3
Dividends paid to Equifax shareholders (143.7) (143.3)
Dividends paid to noncontrolling interests (2.8) (2.5)
Proceeds from exercise of stock options and employee stock purchase plan 18.6 13.5
Payment of taxes related to settlement of equity awards (16.9) (33.0)
Debt issuance costs (6.0) (5.4)
Cash provided by financing activities 63.5 416.5
Effect of foreign currency exchange rates on cash and cash equivalents (6.1) (24.1)
Increase in cash and cash equivalents 127.4 17.0
Cash and cash equivalents, beginning of period 285.2 224.7
Cash and cash equivalents, end of period $ 412.6 $ 241.7